These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 16187969)

  • 61. The Bismuth Skiagram in Investigating Gastro Intestinal Disorders.
    Hospital (Lond 1886); 1907 Nov; 43(1107):207. PubMed ID: 29841842
    [No Abstract]   [Full Text] [Related]  

  • 62. Pharmacokinetics of Antimicrobials in Children with Emphasis on Challenges Faced by Low and Middle Income Countries, a Clinical Review.
    Meesters K; Alemayehu T; Benou S; Buonsenso D; Decloedt EH; Pillay-Fuentes Lorente V; Downes KJ; Allegaert K
    Antibiotics (Basel); 2022 Dec; 12(1):. PubMed ID: 36671218
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evaluation of safety and pharmacokinetics of bismuth-containing quadruple therapy with either vonoprazan or lansoprazole for Helicobacter pylori eradication.
    Huh KY; Chung H; Kim YK; Lee S; Bhatia S; Takanami Y; Nakaya R; Yu KS
    Br J Clin Pharmacol; 2022 Jan; 88(1):138-144. PubMed ID: 34080718
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A Review of Food-Drug Interactions on Oral Drug Absorption.
    Deng J; Zhu X; Chen Z; Fan CH; Kwan HS; Wong CH; Shek KY; Zuo Z; Lam TN
    Drugs; 2017 Nov; 77(17):1833-1855. PubMed ID: 29076109
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Determination of an optimal dosing regimen for fexinidazole, a novel oral drug for the treatment of human African trypanosomiasis: first-in-human studies.
    Tarral A; Blesson S; Mordt OV; Torreele E; Sassella D; Bray MA; Hovsepian L; Evène E; Gualano V; Felices M; Strub-Wourgaft N
    Clin Pharmacokinet; 2014 Jun; 53(6):565-80. PubMed ID: 24535888
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pharmacokinetics of metronidazole, tetracycline and bismuth in healthy volunteers after oral administration of compound tablets containing a combination of metronidazole, tetracycline hydrochloride and bismuth oxide.
    Wu Y; Ding L; Huang NY; Wen AD; Liu B; Li WB
    Drug Res (Stuttg); 2015 Feb; 65(2):74-81. PubMed ID: 24764254
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pylera for the eradication of Helicobacter pylori infection.
    Saleem A; Qasim A; O'Connor HJ; O'Morain CA
    Expert Rev Anti Infect Ther; 2009 Sep; 7(7):793-9. PubMed ID: 19735221
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of two different doses of metronidazole and tetracycline in bismuth triple therapy on eradication of Helicobacter pylori and its resistant strains.
    Roghani HS; Massarrat S; Pahlewanzadeh MR; Dashti M
    Eur J Gastroenterol Hepatol; 1999 Jul; 11(7):709-12. PubMed ID: 10445787
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of food and formulation on the relative bioavailability of bismuth biskalcitrate, metronidazole, and tetracycline given for Helicobacter pylori eradication.
    Spénard J; Aumais C; Massicotte J; Brunet JS; Tremblay C; Grace M; Lefebvre M
    Br J Clin Pharmacol; 2005 Oct; 60(4):374-7. PubMed ID: 16187969
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a prospective, randomized, multicenter, North American trial.
    Laine L; Hunt R; El-Zimaity H; Nguyen B; Osato M; Spénard J
    Am J Gastroenterol; 2003 Mar; 98(3):562-7. PubMed ID: 12650788
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Efficacy and safety of single-triple capsules of bismuth biskalcitrate, metronidazole and tetracycline, given with omeprazole, for the eradication of Helicobacter pylori: an international multicentre study.
    O'Morain C; Borody T; Farley A; De Boer WA; Dallaire C; Schuman R; Piotrowski J; Fallone CA; Tytgat G; Mégraud F; Spénard J;
    Aliment Pharmacol Ther; 2003 Feb; 17(3):415-20. PubMed ID: 12562455
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A single drug for Helicobacter pylori infection: first results with a new bismuth triple monocapsule.
    de Boer WA; van Etten RJ; Schneeberger PM; Tytgat GN
    Am J Gastroenterol; 2000 Mar; 95(3):641-5. PubMed ID: 10710051
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Bismuth-based quadruple therapy for Helicobacter pylori - a single triple capsule plus lansoprazole.
    De Boer WA; Van Etten RJ; Van De Wouw BA; Schneeberger PM; Van Oijen AH; Jansen JB
    Aliment Pharmacol Ther; 2000 Jan; 14(1):85-9. PubMed ID: 10632650
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The influence of coffee with milk and tea with milk on the bioavailability of tetracycline.
    Jung H; Peregrina AA; Rodriguez JM; Moreno-Esparza R
    Biopharm Drug Dispos; 1997 Jul; 18(5):459-63. PubMed ID: 9210983
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Minocycline for acne. Food reduces minocycline's bioavailability.
    Meyer FP
    BMJ; 1996 Apr; 312(7038):1101. PubMed ID: 8616441
    [No Abstract]   [Full Text] [Related]  

  • 76. Influence of the diet on bioavailability of tetracycline.
    Cook HJ; Mundo CR; Fonseca L; Gasque L; Moreno-Esparza R
    Biopharm Drug Dispos; 1993 Aug; 14(6):549-53. PubMed ID: 8218972
    [No Abstract]   [Full Text] [Related]  

  • 77. Clinical pharmacokinetics of metronidazole.
    Ralph ED
    Clin Pharmacokinet; 1983; 8(1):43-62. PubMed ID: 6340904
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.